triazolam has been researched along with Dental Diseases in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of this study was to determine the pharmacokinetic behavior of triazolam in children." | 1.30 | Pharmacokinetics of oral triazolam in children. ( Awamura, K; Coldwell, SE; Domoto, P; Karl, HW; Kharasch, ED; Leroux, B; Mautz, D; Milgrom, P; Weinstein, P, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karl, HW | 1 |
| Milgrom, P | 1 |
| Domoto, P | 1 |
| Kharasch, ED | 1 |
| Coldwell, SE | 1 |
| Weinstein, P | 1 |
| Leroux, B | 1 |
| Awamura, K | 1 |
| Mautz, D | 1 |
1 other study available for triazolam and Dental Diseases
| Article | Year |
|---|---|
Pharmacokinetics of oral triazolam in children.
Topics: Biological Availability; Child; Dental Care for Children; Female; Half-Life; Humans; Hypnotics and S | 1997 |